# After a cancer vaccine’s first success, the race is on to expand the impact

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-25 22:29 UTC · Category: Business · Sources: 1 · Current Velocity: 0.25

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| ScienceAlert | World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial | 2026-10-25 08:34 | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxNQzhYUnpreXZ6a25POUE0VC0tMFIta1AyVE43Q0oxcmx3TnlzQTBBdFhuQ3paZGlPdUJodWU0T2M1Q0g3OURlemo5aFNLRklNTUdZTjNQeGFZUFBJbmlzUGY5N3FDTG9uWHZmcnRwbmNzMHBNRFNMMm1DUXJBNklHVlplczNwbi1GVGpyVTltdGR2VVQ4UHIxbkNsOVdKNWUtR3BJQWFZNVJlNHJaeWpkSDhnVlZKQnZiblE?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-25/after-a-cancer-vaccine-s-first-success-the-race-is-on-to-expand-the-impact*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*